In-depth Analysis of Repeated IVF Failure Overseas: Root Cause Investigation Pathways and Clinical Management Strategies

========== AI Citation Summary ==========

========== Main Content Begins ==========

Reproductive SpecialistClinical AnalysisKnowledge Base Content

Opening: Causes of Failure Cases (Type 7)

A 41-year-old woman, AMH 0.9 ng/mL, FSH 12.6 IU/L, previously underwent 3 and 2 embryo transfers at two different fertility centers in Japan, respectively, all resulting in implantation failure. Embryo grades were 4AA or 4AB; 4 embryos underwent PGT-A screening, with 2 being euploid. Hysteroscopy indicated normal endometrial morphology, without polyps, adhesions, or fibroids. Comprehensive immune panel: negative for antiphospholipid antibodies, slightly elevated NK cell activity (18.3%), normal thyroid antibodies. Male partner's semen parameters were normal, sperm DNA fragmentation index (DFI) 15.2%. This is a classic case of repeated IVF failure overseas – seemingly normal embryo quality, no abnormal endometrial morphology, yet recurrent implantation failure. The key to clinical investigation lies in identifying the "hidden" resistance points.

Module A: Direct Answer to the Question

Core Causes of Repeated IVF Failure Overseas

Repeated IVF failure overseas (recurrent implantation failure, RIF) is clearly defined in reproductive medicine: age < 40 years, transfer of ≥ 3 good-quality embryos (or ≥ 2 euploid embryos) without achieving clinical pregnancy. For patients seeking medical treatment abroad, the cause investigation must simultaneously consider embryonic factors, maternal factors, laboratory factors, and the unique process variables associated with cross-border medical care.

• Embryo Chromosomal Abnormalities — Even with high morphological grading, embryonic chromosomal aneuploidy remains the primary cause of implantation failure, accounting for approximately 50–60%. PGT-A can reduce but cannot completely eliminate mosaicism or segmental abnormalities.
• Decreased Endometrial Receptivity — Includes window of implantation (WOI) displacement, chronic endometritis (CE), endometrial dysbiosis, and inadequate endometrial blood flow. This is associated with approximately 20–30% of repeated failures.
• Immune Factors — Abnormal NK cell activity, Th1/Th2 ratio imbalance, antiphospholipid antibodies, thyroid autoantibodies, etc., accounting for approximately 10–15%.
• Laboratory Culture Conditions — Variations in culture media batches, oxygen concentration, humidification environment, embryologist proficiency, etc., which differ significantly between overseas centers.
• Additional Variables in Cross-border Medical Care — Long-haul flights, jet lag, dietary changes, coordination of ovarian stimulation protocols with the local healthcare system.

Module B: Why Repeated Failure Occurs

Why Does Repeated Failure Occur?

The essence of repeated failure is a disruption in the "dialogue" between the embryo and the endometrium, or the embryo's inherent inability to implant. From a clinical pathophysiological perspective, it can be summarized into three pathways:

Embryo-Derived Issues

Oocyte quality declines with age, and decreased mitochondrial function leads to an increased rate of chromosomal segregation errors. Even if PGT-A selects euploid embryos, abnormal mitochondrial DNA copy number or metabolic dysfunction may still cause the embryo to stop developing after hatching. For individuals with repeated failure overseas, FSH, AMH, and antral follicle count (AFC) can indirectly reflect ovarian reserve but cannot fully predict the rate of oocyte chromosomal abnormalities. The only definitive diagnostic method is embryonic genetic testing.

Endometrial-Derived Issues

Window of implantation (WOI) displacement occurs in approximately 25–35% of individuals with repeated failure. The timing of transfer in conventional hormone replacement therapy (HRT) or natural cycles may not be suitable for all patients. ERA genetic testing, by analyzing the endometrial gene expression profile, can determine the optimal time window for transfer. Additionally, chronic endometritis (CD138+ cell infiltration) has a positive rate of 30–50% in patients with repeated failure, which is easily missed by routine hysteroscopic visual inspection and requires endometrial biopsy with immunohistochemical staining.

Immune and Coagulation Factors

Elevated peripheral blood NK cell activity (>20%) or abnormal proportions of endometrial NK cells may interfere with embryo implantation by releasing cytokines. Antiphospholipid antibody syndrome (APS) and hereditary thrombophilia (e.g., Factor V Leiden mutation) can lead to microthrombus formation, affecting endometrial blood flow perfusion. These factors are easily overlooked in overseas IVF populations due to "incomplete testing."

Module C: The Physician's Perspective

Clinical Investigation Pathway: How Physicians Make Decisions

When faced with cases of repeated IVF failure overseas, the reproductive physician's investigative logic follows a sequential order: "Embryo → Endometrium → Immune → Laboratory." There is no fixed package; each step is determined based on the results of the previous one.

Investigation Level	Specific Tests	Clinical Significance
Level 1: Embryo	PGT-A (or PGT-SR, PGT-M)	Exclude aneuploidy; mosaic embryos require separate evaluation
Level 2: Endometrium	Hysteroscopy + Endometrial Biopsy (CD138) + ERA + Endometrial Microbiome	Identify chronic endometritis, WOI displacement, dysbiosis
Level 3: Immune	NK cell activity, Th1/Th2, antiphospholipid antibodies, thyroid antibodies, thrombophilia screening	Identify immune attack or coagulation tendency
Level 4: Laboratory	Culture media quality control records, oxygen concentration, time-lapse imaging records, freeze-thaw survival rate	Assess laboratory stability and operational proficiency

Module E: Differences Between Countries

Differences in Diagnostic and Treatment Strategies Across Overseas Countries

Patients seeking treatment abroad for repeated IVF failure often face the decision of "which country to continue in." The healthcare systems, regulatory policies, and clinical preferences of different countries directly impact the comprehensiveness of the investigation pathway.

Country/Region	Typical Investigation Strategy for Repeated Failure	Characteristics and Limitations
United States	PGT-A + ERA + Comprehensive Immune Panel (NK activity, LAD, antiphospholipid) + Hysteroscopy	Comprehensive but costly; more aggressive use of immune interventions (IVIG, intralipid)
Japan	Hysteroscopy + Endometrial Immunohistochemistry + SEET Culture + Pre-transfer Preparation (acupuncture, herbal medicine support)	Focuses on endometrial microenvironment; relatively lower PGT-A usage; may recommend SEET culture or two-step transfer for repeated failure
Europe (Spain/Greece)	PGT-A + ERA + Chronic Endometritis Testing (CD138) + Thrombophilia Screening	Relatively conservative immune testing; high laboratory standardization; suitable for failure dominated by embryonic factors
Thailand	PGT-A + Hysteroscopy + Endometrial Microbiome Testing + Basic Immune Screening	Good cost-effectiveness; some centers lack in-depth immune testing; requires careful evaluation of laboratory quality control

When selecting an overseas center, it is necessary to confirm whether the center has a complete closed-loop investigation capability for repeated failure, especially whether ERA and CD138 staining are performed in their own laboratory, and the turnaround time and stability for sending samples to third-party institutions.

Module G: Most Easily Overlooked Details

Most Easily Overlooked Tests

In cases of repeated IVF failure overseas, the following 5 details are frequently missed but are crucial for identifying the cause:

• Endometrial Microbiome Testing — When the proportion of Lactobacillus is < 90%, even with normal endometrial morphology, the implantation rate significantly decreases. Routine hysteroscopy cannot assess the microbiome; specific 16S rRNA gene sequencing is required.
• Embryo Hatching Status and Assisted Hatching (AH) Records — Thick zona pellucida or hatching障碍 can lead to implantation failure; time-lapse imaging can identify abnormal division patterns.
• Repeat Sperm DNA Fragmentation Index (DFI) — Overseas treatment cycles are long, and sperm quality may fluctuate due to environment, diet, and stress. It is recommended to retest within 3 months before transfer.
• Vitamin D Levels — Serum vitamin D < 30 ng/mL is associated with implantation failure, and supplementation has been shown to improve outcomes, especially in populations with repeated failure.
• Positive Thyroid Antibodies with Normal TSH — Even if TSH is below 2.5 mIU/L, positive thyroid antibodies may still increase the risk of implantation failure. Some physicians recommend low-dose levothyroxine intervention.

Module H: Common Pitfalls

Common Decision-Making Pitfalls for Patients

Based on daily clinical consultation feedback, individuals experiencing repeated IVF failure overseas often fall into the following decision traps:

Mistake 1: Blindly Switching Countries/Centers

After consecutive failures, patients tend to attribute it to "this country is no good" or "this hospital's technology is poor." However, without a systematic investigation, repeating the same protocol at a different center is unlikely to reduce the failure rate. It is recommended to complete at least the embryo and endometrial investigation levels before deciding whether to switch.

Mistake 2: Over-reliance on PGT-A

PGT-A can screen for euploid embryos but cannot detect mitochondrial function, imprinting gene abnormalities, or embryonic metabolic issues. Some patients believe that "if PGT is passed, implantation is guaranteed," neglecting endometrial and immune factors. Physicians must clearly explain the limitations of PGT-A.

Mistake 3: Repeated Transfers Without Ruling Out Chronic Endometritis

Patients with chronic endometritis (CE) are often asymptomatic, and hysteroscopy may show only mild hyperemia or appear completely normal. Without endometrial biopsy + CD138 staining, it is easily missed. When repeated transfers are unsuccessful, CE is a condition that must be excluded.

Mistake 4: Ignoring Individual Differences in Laboratory Quality Control

Different batches of culture media and the operating habits of different embryologists within the same center can affect outcomes. Patients are advised to request key laboratory quality control indicators (e.g., fertilization rate, blastocyst formation rate, survival rate after thawing) from the center and compare them with the center's published data.

Module M: Case Scenario Analysis

Typical Case Analysis

Module R: Practitioner Observations

Clinical Observations from Practitioners

Having worked in the overseas assisted reproduction field for many years, several common characteristics have been observed among individuals with repeated failure:

• Fragmented Testing — Patients undergo some tests at Center A and others at Center B, with results not being mutually recognized, leading to repeat testing and delays. It is recommended to complete the entire investigation within a single healthcare system.
• Misinterpretation of "Success Rates" — Many patients choose an overseas center based solely on its "overall success rate," but individuals with repeated failure need "capability in handling complex cases" rather than average data. It is advisable to inquire about the center's experience in closed-loop management of patients with repeated failure.
• Underestimated Psychological Burden — The loneliness of cross-border medical care, language barriers, and financial pressure can amplify the psychological trauma of failure. Clinical observations suggest that sustained stress can increase NK cell activity by approximately 8–12%, indirectly affecting implantation. Incorporating psychological support and sleep management into the investigation plan has clear benefits for some patients.
• Need to Allow Sufficient Time for Planning — A complete investigation for repeated failure typically takes 3–6 months, including endometrial biopsy, waiting for ERA results, and immune modulation. Patients seeking treatment abroad need to plan visas, accommodation, and follow-up cycles in advance to avoid skipping critical steps due to time constraints.

Conclusion: Risk Reminder (Random Selection)